A propensity score-matched comparison of neoadjuvant chemoradiotherapy with cisplatin-5FU and carboplatin-paclitaxel in locally advanced esophageal squamous cell carcinoma: A Turkish oncology group study.

Fatih Gürler Fatih Tay Zehra Sucuoglu Isleyen Tahir Yerlikaya Haci Mehmet Turk Selin Aktürk Esen Osman SütçüoğluDeniz IşıkBüşra NiğdelioğluMiraç ÖzenElif Sahin Teoman Sakalar Nilay Sengul Samanci Özkan Alanİlhan HacıbekiroğluEfnan AlginMelek Karakurt YılmazHacı Mehmet TürkÖmür Berna Çakmak Öksüzoğlu Aydın Yavuz Osman YukselHüseyin BoraOzan Yazıcı Ahmet Özet Nuriye Ozdemir

Published in: Cancer medicine (2024)

Favorable PFS and pCR rates and a comparable OS were obtained with the CROSS regimen over the CF regimen as neoadjuvant chemoradiotherapy in patients with ESCC.

Keyphrases

locally advanced
rectal cancer
phase ii study
neoadjuvant chemotherapy
squamous cell carcinoma
radiation therapy
cystic fibrosis
palliative care
clinical trial
phase iii
lymph node